LifePoint Hospitals, Inc. (NASDAQ: LPNT) announced today that it is
extending the expiration date of its previously announced consent
solicitation (the “Consent Solicitation”) seeking consents from holders
of its $400 million outstanding principal amount of 6.625% Senior Notes
due 2020 (the “Notes”) for amendments to certain provisions of the
indenture governing the Notes.
The Consent Solicitation, which was previously scheduled to expire at
5:00 p.m., New York City time, on August 20, 2013, will be extended to
5:00 p.m., New York City time, on August 21, 2013, unless further
extended or terminated by the Company.
All other terms and conditions of the Consent Solicitation, as set forth
in the Consent Solicitation Statement dated July 30, 2013 (the “Consent
Solicitation Statement”), remain the same.
Copies of the Consent Solicitation Statement and the consent form may be
obtained by holders of the Notes from the Information and Tabulation
Agent for the Consent Solicitation, D.F. King & Co., Inc., at (800)
949-2583 (toll-free), (212) 269-5550 (collect) or by email: lifepoint@dfking.com.
Barclays Capital Inc. is the Solicitation Agent for the Consent
Solicitation. Questions may be directed to Barclays Capital Inc. at
(800) 438-3242 (toll-free) or (212) 528-7581 (collect).
About LifePoint Hospitals
LifePoint Hospitals, Inc. is a leading hospital company focused on
providing quality healthcare services close to home. Through its
subsidiaries, LifePoint operates 57 hospital campuses in 20 states. With
a mission of “Making Communities Healthier®,” LifePoint is the sole
community hospital provider in the majority of the communities it
serves. More information about the Company, which is headquartered in
Brentwood, Tennessee, can be found on its website, www.LifePointHospitals.com.
All references to “LifePoint,” “LifePoint Hospitals,” or the “Company”
used in this release refer to LifePoint Hospitals, Inc. or its
affiliates.
Forward-looking Statements
In addition to historical information, this report may contain
certain statements that constitute "forward-looking statements" within
the meaning of the Private Securities Litigation Reform Act of 1995. Such
forward-looking statements, together with other statements that are not
historical, are based on management's current expectations and involve
known and unknown risks, uncertainties, contingencies and other factors
that could cause results, performance or achievements to differ
materially from those stated. The most significant of these risks
and uncertainties are described in the Company's Form 10-K, Form 10-Q
and Form 8-K reports filed with the Securities and Exchange Commission.
Should one or more of these risks or uncertainties materialize or
should underlying assumptions prove incorrect, the Company's actual
results, performance or achievements could differ materially from those
expressed in, or implied by, such forward-looking statements. Readers
are cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date hereof. Except as
otherwise required by law, the Company does not undertake any obligation
to publicly release any revisions to these forward-looking statements to
reflect events or circumstances after the date hereof or to reflect the
occurrence of unanticipated events.
Copyright Business Wire 2013